Fondazione Ri.MED

[On Demand]
Founded by the Italian Government as international private-public partnership, its mission is to develop biotechnological and biomedical translational research approaches, disseminate scientific knowledge and train qualified professionals in the Life Science sector. Translational research is focused on basic research, preclinical research and development of new therapies, medical devices and biomarkers, and finally clinical trial. For the nature of the founding partners, as CNR, the University of Pittsburgh and UPMC, the Foundation has developed translational research programs. With the partnership with ISMETT, RiMED’s fostered multidisciplinary projects in reg med and cellular therapies including a GMP cell factory to support clinical trial. The research in Ri.MED follows 3 main approaches: bio-engineering, drug discovery and vaccine development, and regenerative medicine, focusing on therapeutic areas as oncology, aging, neurodegeneration, infectious and organ failure diseases.
Company Type:
Academic Campus/Advocacy/Non-Profit/Other
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Not Provided
Development Phase of Primary Product:
Not Provided
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
fondazione Ri.MED